Femke Bouwman

DR.

20062020
If you made any changes in Pure these will be visible here soon.

Research Output 2006 2020

Filter
Review article
2018

Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia

Boccardi, M., Festari, C., Altomare, D., Gandolfo, F., Orini, S., Nobili, F., Frisoni, G. B., Agosta, F., Arbizu, J., Bouwman, F., Drzezga, A., Nestor, P., Walker, Z. & For the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, 1 Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1470-1486 17 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders

For the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1557-1566

Research output: Contribution to journalReview articleAcademicpeer-review

Clinical utility of FDG-PET for the clinical diagnosis in MCI

EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1497-1508

Research output: Contribution to journalReview articleAcademicpeer-review

Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia

EANM-EAN Task Force for the recommendation of FDG PET for Dementing Neurodegenerative Disorders, 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1534-1545

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease

EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1487-1496

Research output: Contribution to journalReview articleAcademicpeer-review

Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review

de Wilde, A., van Buchem, M. M., Otten, R. H. J., Bouwman, F., Stephens, A., Barkhof, F., Scheltens, P. & van der Flier, W. M., 28 Jul 2018, In : Alzheimer's Research & Therapy. 10, 1, p. 72

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus

the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, 2018, In : European Journal of Neurology. 25, 10, p. 1201-1217

Research output: Contribution to journalReview articleAcademicpeer-review